CAPRICOR THERAPEUTICS, INC. - 8-K Filing
Capricor Therapeutics held its annual meeting on June 4, 2026, where shareholders elected eight directors with vote totals ranging from 21,114,485 to 25,482,880 votes in favor. The appointment of Rose, Snyder & Jacobs LLP as auditors was ratified by a majority (43,057,620 for), and shareholders approved named executive officer compensation with 24,336,434 votes in favor. However, the proposed amendment to the Certificate of Incorporation regarding officer exculpation did not receive shareholder approval.
Tickers: $CAPR